<table sstyle="width:80%" align="center" border=1>
<tr>
<th>mv</th>
<th>dw</th>
<th>HMMCrowd</th>
</tr>
<tr>
<td width=33%>
[6, 10] clinical and laboratory characteristics<br>[88, 93] duration of the main symptoms<br>[115, 117] ulcer scarring<br>[122, 132] dynamics of serum LF and TNF-alpha levels.<br></td>
<td width=33%>
[6, 10] clinical and laboratory characteristics<br>[54, 58] lactoferrin (LF)<br>[59, 70] tumour necrosis factor-alpha (TNF-alpha),<br>[88, 93] duration of the main symptoms<br>[115, 117] ulcer scarring<br>[122, 132] dynamics of serum LF and TNF-alpha levels.<br></td>
<td width=33%>
[6, 10] clinical and laboratory characteristics<br>[52, 70] measurements of lactoferrin (LF) and tumour necrosis factor-alpha (TNF-alpha),<br>[71, 74] standard analyses.<br>[86, 97] reduction in duration of the main symptoms of the gastric ulcer<br>[115, 132] ulcer scarring and had beneficial effect on dynamics of serum LF and TNF-alpha levels.<br></td>
</tr>
